Accelerating Cell and Gene Therapy Commercialization

A winning development strategy for corporate success depends on the right balance of risk and reward across your portfolio and for each program. We guide you through all aspects of your early development planning. This includes:

• Corporate and partnering strategy
• Indication prioritization and development strategies across the spectrum of advanced therapies
• Analogue identification, analysis and insights generation; critical development strategic “must-dos”
• Creating, contextualizing, and maintaining a framework of relevant information to continually monitor the evolving CGT landscape

We support and guide commercialization teams and cross-functional stakeholders through asset commercialization and brand planning; bridging the transition from clinical development / target product profile (TPP) refinement to early launch planning and beyond. This includes:

• Launch commercialization, annual brand strategy, and tactical plans
• Patient and product journey considerations unique to cell and gene therapy assets
• Analogue insights and critical commercial strategic “must-dos”

A systematic review of your market landscape and evaluation of different market possibilities provides a roadmap to demonstrate value and differentiation. We help you understand potential future market needs and scenarios, and develop strategies and contingency plans that address the complex variables associated with the introduction of cell and gene therapies. For example:

• Opportunity assessment, valuation, and forecasting
• Market research and landscaping
• Scenario planning for potential study results and regulatory outcomes
• Treatment evolution; market receptivity to “off-the-shelf” versus one-time, “one and done” treatment propositions
• Manufacturing complexities and slot availability through to patient / caregiver community activation

Given the pace of R&D in the cell and gene therapies space, in-class and cross-class competitors can evolve rapidly. We are experts at competitive landscaping, building, prioritizing, and characterizing competitive threats and your differentiated opportunities that stretch thinking and enable confident, future-proof decisions.

Preparing for and launching a cell and gene therapy, where there may be no (or limited) existing treatment, requires in-depth assessment and strategic positioning within the landscape. We work with teams to define objectives to shape the market, justify the value proposition, and shift beliefs. We can help you:

• Consider bio-ethical considerations that inform lexicon development of key messages to the external environment
• Support extensive organizational engagement to develop implementation plans
• Anticipate and address potential misperceptions and unrealistic expectations around efficacy and safety

We support you throughout the entire launch process—from determining the right strategy, through to coordination and tracking of activities, and ensuring an aligned organization. Our proprietary launch excellence platform and framework is tailored to your precise needs, to build and track pre-launch to post-launch planning and implementation. This consolidation and visibility of progress and mapping of interdependencies is particularly critical for cell and gene therapies given the number of unique considerations versus traditional launches.